1 day ago
1
Hailshadow/iStock via Getty Images
- Incyte (NASDAQ:INCY) is up ~3% in Tuesday trading following word it will present late-breaking data on INCA033989, an anti-mutant calreticulin (mutCALR)-directed monoclonal antibody for thrombocythemia at the European Hematology Association Congress later this month.
- "We believe the data that will
English (US) ·